Akero Therapeutics, Inc. (0K4.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 08:00AM CEST
| Previous Close | 10.20 |
| Open | 10.10 |
| Bid | 9.80 x N/A |
| Ask | 10.00 x N/A |
| Day's Range | 10.10 - 10.10 |
| 52 Week Range | 7.40 - 23.00 |
| Volume | |
| Avg. Volume | 15 |
| Market Cap | 352.372M |
| Beta (5Y Monthly) | 0.54 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
We're Hopeful That Akero Therapeutics (NASDAQ:AKRO) Will Use Its Cash Wisely
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
- Zacks
Is Akero Therapeutics, Inc. (AKRO) Outperforming Other Medical Stocks This Year?
Here is how Akero Therapeutics, Inc. (AKRO) and Butterfly Network, Inc. (BFLY) have performed compared to their sector so far this year.
- Zacks
Wall Street Analysts Think Akero Therapeutics, Inc. (AKRO) Could Surge 92%: Read This Before Placing a Bet
The mean of analysts' price targets for Akero Therapeutics, Inc. (AKRO) points to a 91.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
© 2022 Yahoo. All rights reserved.
